Delivery Order 75N95019D00026-75N95019F00088
Award Date 9/26/19
Potential Completion Date 9/25/24
Potential Value $46M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Paramus, NJ 07652, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Psychogenics Inc. was awarded a $1.8 million cost-plus-fixed-fee delivery order contract by the National Institute of Neurological Disorders and Stroke to support the Preclinical Screening Platform for Pain program. Under this contract, Psychogenics will provide identification and validation of novel pain-related endpoints and animal models of pain, as well as profiling of investigational agents in rodent and non-rodent species excluding non-human primates. This delivery order was issued against...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $65,840,279.00 cost-plus-fixed-fee delivery order contract to Psychogenics Inc., a for-profit contract research organization located in Paramus, New Jersey. The contract is for the "Screening of Investigational Agents through the NINDS Preclinical Screening Platform for Pain (PSPP)," which supports the NIH's Helping to End Addiction Long-term (HEAL) initiative. The contract involves comprehensive in-vitro and...
- This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $520,896.73 contract is for the evaluation of drug efficacy in a rat model of neuropathic pain. Lovelace Biomedical Research Institute has experience conducting animal studies, including for federal...
- This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
- This is a $244,800 contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to RPK Associates, LLC, a small business. The contract is for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products for NIH drug discovery and development programs, including the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics)...
- This federal contract award, valued at $1,884,275.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pharmalex US Corporation for Biologics Subject Matter Expert (SME) Consulting Services. The contract is a total small business set-aside, with a period of performance through April 14, 2025. The award is in support of NINDS programs such as the Blueprint Neurotherapeutics Network Biologics (BPN-Biologics), the Ultra-Rare Gene Therapy...
- This is a $3,893,053.00 cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit organization. The contract is for the characterization of a non-addictive small molecule therapeutic for the management of non-cancer pain, with a period of performance from September 18, 2020 to September 17, 2022, and an ultimate completion date of April 28, 2025....
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Helix Biostructures LLC, a self-certified small disadvantaged business. The $24,150 contract is for the purchase of a functional near-infrared spectroscopy (fNIRS) system and related accessories to support a study on nociception and pain sensitivity in individuals with intellectual disability. The system will be used to measure...
- This federal contract award is to 10X Genomics, Inc., a life sciences technology company, by the National Institute of Neurological Disorders and Stroke (NINDS), an institute of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $24,999.00 firm fixed price Delivery Order is for the provision of 10X Genomics optimization slides, reagents kits, and reagent delivery methods to support NINDS research efforts into neurological diseases and disorders....